Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…<2.6 mmol/L, triglyceride concentration <2.0 mmol/L, and use of renin-angiotensin system inhibitors.JADE, Joint Asia Diabetes Evaluation; MET, metabolic equivalent…
…pendent predictors of CRR, but not RASi usage.Conclusion Adding RASi to standard induction therapy provided no additive benefit for …
… The proportion of guideline-directed treatment was suboptimal: sodium-glucose cotransporter-2 inhibitors (36.5%), renin-angiotensin system inhibitors (56.5%) and only 3…
…the consolidation of four foundational pharmacological pillars: beta-blockers, renin-angiotensin system inhibitors or angiotensin receptor-ne…
…to mid 2000s. These trends, alongside decreasing use of several antihypertensive drugs and in the context of worsening population level control, may r…
…is. In CKD+HF, CKD+T2D and HF+T2D groups, prescription rates of renin-angiotensin system inhibitors (71%, 64.1% and 74.4%), beta-blockers (53.1%,36.2% and 55.1%), …